FDA Says Fusion's Claims For Facial 'Lift' Products Make Them Drugs

摘要

FDA expects Fusion Brands' written response to an April 24 warning letter within the next two weeks,the agency told "The Rose Sheet" May 30.According to FDA,Fusion Brands is in violation of the Federal Food,Drug and Cosmetic Act for labeling associated with three products under its LiftFusion skin-care brand.